BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Elaskalani O, Razak NBA, Falasca M, Metharom P. Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer. World J Gastrointest Oncol 2017; 9(1): 37-41 [PMID: 28144398 DOI: 10.4251/wjgo.v9.i1.37]
URL: https://www.wjgnet.com/1948-5204/full/v9/i1/37.htm
Number Citing Articles
1
Zhaoyan Qiu, Yi Chu, Bing Xu, Qian Wang, Mingzuo Jiang, Xiaowei Li, Gang Wang, Pengfei Yu, Guoxiao Liu, Hua Wang, Huijie Kang, Jiayu Liu, Yu Zhang, Jian-Ping Jin, Kaichun Wu, Jie Liang. Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinomaOncotarget 2017; 8(34): 56428 doi: 10.18632/oncotarget.17701
2
Rita Zilhão, Hélia Neves. Molecular and Cell Biology of CancerLearning Materials in Biosciences 2019; : 159 doi: 10.1007/978-3-030-11812-9_9
3
Zhaotao Wang, Zhi Liu, Guoyong Yu, Xiaohu Nie, Weiqiang Jia, Ru-en Liu, Ruxiang Xu. Paeoniflorin Inhibits Migration and Invasion of Human Glioblastoma Cells via Suppression Transforming Growth Factor β-Induced Epithelial–Mesenchymal TransitionNeurochemical Research 2018; 43(3): 760 doi: 10.1007/s11064-018-2478-y
4
Xiaoqing Wan, Jiaxin Hou, Shurong Liu, Yanli Zhang, Wenqing Li, Yanru Zhang, Yi Ding. Estrogen Receptor α Mediates Doxorubicin Sensitivity in Breast Cancer Cells by Regulating E-CadherinFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.583572
5
Suresh Chava, Meher B. Gayatri, Aramati B.M. Reddy. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy2019; : 25 doi: 10.1016/B978-0-12-817661-0.00003-2
6
Camille Huart, Jia-Wei Chen, Benjamin Le Calvé, Carine Michiels, Anne-Catherine Wéra. Could Protons and Carbon Ions Be the Silver Bullets Against Pancreatic Cancer?International Journal of Molecular Sciences 2020; 21(13): 4767 doi: 10.3390/ijms21134767
7
Ling Xiong, Hong Lu, Ying Hu, Wei Wang, Rong Liu, Xinpeng Wan, Jianjiang Fu. In vitro anti-motile effects of Rhoifolin, a flavonoid extracted from Callicarpa nudiflora on breast cancer cells via downregulating Podocalyxin-Ezrin interaction during Epithelial Mesenchymal TransitionPhytomedicine 2021; 93: 153486 doi: 10.1016/j.phymed.2021.153486
8
Zhengjun Lin, Shiyao Lu, Xubin Xie, Xuyang Yi, He Huang. Noncoding RNAs in drug-resistant pancreatic cancer: A reviewBiomedicine & Pharmacotherapy 2020; 131: 110768 doi: 10.1016/j.biopha.2020.110768
9
Yu-Shen Yang, Dan Wen, Xue-Feng Zhao. Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis—in vitro and in vivoNaunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(6): 1263 doi: 10.1007/s00210-020-02032-8
10
De Zeng, Yuan‐Ke Liang, Ying‐Sheng Xiao, Xiao‐Long Wei, Hao‐Yu Lin, Yang Wu, Jing‐Wen Bai, Min Chen, Guo‐Jun Zhang. Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple‐negative breast cancer cells International Journal of Cancer 2020; 147(2): 490 doi: 10.1002/ijc.32911
11
Aleksandra Adamska, Omar Elaskalani, Aikaterini Emmanouilidi, Minkyoung Kim, Norbaini Binti Abdol Razak, Pat Metharom, Marco Falasca. Molecular and cellular mechanisms of chemoresistance in pancreatic cancerAdvances in Biological Regulation 2018; 68: 77 doi: 10.1016/j.jbior.2017.11.007
12
Zhihai Yuan, Zhen Yang, Weiqin Li, Aimei Wu, Zhixiang Su, Bin Jiang. Exosome-Mediated Transfer of Long Noncoding RNA HOTAIR Regulates Temozolomide Resistance by miR-519a-3p/RRM1 Axis in GlioblastomaCancer Biotherapy and Radiopharmaceuticals 2020;  doi: 10.1089/cbr.2019.3499
13
Mohini Singh, Nicolas Yelle, Chitra Venugopal, Sheila K. Singh. EMT: Mechanisms and therapeutic implicationsPharmacology & Therapeutics 2018; 182: 80 doi: 10.1016/j.pharmthera.2017.08.009
14
Lingyun Wu, Sugandha Saxena, Rakesh K. Singh. Tumor MicroenvironmentAdvances in Experimental Medicine and Biology 2020; 1224: 1 doi: 10.1007/978-3-030-35723-8_1
15
Xia Ma, Bei Wang, Xiaofang Wang, Yujiao Luo, Wufang Fan, Masaru Katoh. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cellsPLOS ONE 2018; 13(4): e0192436 doi: 10.1371/journal.pone.0192436
16
Tumor-Associated Neutrophils in Cancer: Going ProCancers 2019; 11(4): 564 doi: 10.3390/cancers11040564
17
Ying-Sheng Xiao, De Zeng, Yuan-Ke Liang, Yang Wu, Mei-Fang Li, Yu-Zhu Qi, Xiao-Long Wei, Wen-He Huang, Min Chen, Guo-Jun Zhang. Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cellsCancer Letters 2019; : 156 doi: 10.1016/j.canlet.2018.09.031
18
Nusrat J. Epsi, Sukanya Panja, Sharon R. Pine, Antonina Mitrofanova. pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinomaCommunications Biology 2019; 2(1) doi: 10.1038/s42003-019-0572-6
19
Tuan Luu. Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic CancerFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.646399
20
Sofia Kamlund, Birgit Janicke, Kersti Alm, Robert L. Judson-Torres, Stina Oredsson. Quantifying the Rate, Degree, and Heterogeneity of Morphological Change during an Epithelial to Mesenchymal Transition Using Digital Holographic CytometryApplied Sciences 2020; 10(14): 4726 doi: 10.3390/app10144726
21
Thomas Brabletz, Raghu Kalluri, M. Angela Nieto, Robert A. Weinberg. EMT in cancerNature Reviews Cancer 2018; 18(2): 128 doi: 10.1038/nrc.2017.118
22
Aarif Siddiqui, Paolo Ceppi. A non-proliferative role of pyrimidine metabolism in cancerMolecular Metabolism 2020; 35: 100962 doi: 10.1016/j.molmet.2020.02.005
23
Hye-ran Moon, Altug Ozcelikkale, Yi Yang, Bennett D. Elzey, Stephen F. Konieczny, Bumsoo Han. An engineered pancreatic cancer model with intra-tumoral heterogeneity of driver mutationsLab on a Chip 2020; 20(20): 3720 doi: 10.1039/D0LC00707B
24
James H. Monkman, Erik W. Thompson, Shivashankar H. Nagaraj. Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous DiseaseCancers 2019; 11(11): 1745 doi: 10.3390/cancers11111745
25
LiYa Huang, BinWu Ma, JunWen Ma, Feng Wang. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathwayBiochemical and Biophysical Research Communications 2017; 493(4): 1510 doi: 10.1016/j.bbrc.2017.10.006
26
Abdul K. Siraj, Poyil Pratheeshkumar, Sasidharan Padmaja Divya, Sandeep Kumar Parvathareddy, Rong Bu, Tariq Masoodi, Yan Kong, Saravanan Thangavel, Nasser Al-Sanea, Luai H. Ashari, Alaa Abduljabbar, Samar Al-Homoud, Fouad Al-Dayel, Khawla S. Al-Kuraya. TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRCMolecular Cancer Therapeutics 2019; 18(7): 1312 doi: 10.1158/1535-7163.MCT-18-1378
27
Yongjing Xiang, Qing Zhang, Shujun Wei, Cong Huang, Zhengsheng Li, Yongxiang Gao. Paeoniflorin: a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activitiesJournal of Pharmacy and Pharmacology 2020; 72(4): 483 doi: 10.1111/jphp.13204
28
Marco Cordani, Raffaele Strippoli, Álvaro Somoza. Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer TreatmentCancers 2019; 12(1): 25 doi: 10.3390/cancers12010025
29
Bikash Chandra Jena, Siddik Sarkar, Lipsa Rout, Mahitosh Mandal. The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistanceCancer Letters 2021; 520: 222 doi: 10.1016/j.canlet.2021.08.002
30
Yue Yu, Fei Ding, Meng Gao, Yi Jia, Le Ren. Establishment and characterization of the gemcitabine‑resistant human pancreatic cancer cell line SW1990/gemcitabineOncology Letters 2019;  doi: 10.3892/ol.2019.10627
31
Xiaomeng Zhang, Ningyi Ma, Weiqiang Yao, Shuo Li, Zhigang Ren. RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancerCancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-1077-6